Hisamitsu Pharmaceutical 관리
관리 기준 확인 1/4
Hisamitsu Pharmaceutical's CEO is Kazue Nakatomi, appointed in May 2015, has a tenure of 9.5 years. directly owns 0.33% of the company’s shares, worth ¥1.10B. The average tenure of the management team and the board of directors is 1.3 years and 10.5 years respectively.
주요 정보
Kazue Nakatomi
최고 경영자
n/a
총 보상
| CEO 급여 비율 | n/a |
| CEO 임기 | 9.5yrs |
| CEO 소유권 | 0.3% |
| 경영진 평균 재임 기간 | 1.3yrs |
| 이사회 평균 재임 기간 | 10.5yrs |
최근 관리 업데이트
Recent updates
We Think Hisamitsu Pharmaceutical (TSE:4530) Can Stay On Top Of Its Debt
Nov 04
Hisamitsu Pharmaceutical's (TSE:4530) Solid Earnings May Rest On Weak Foundations
Oct 17Hisamitsu Pharmaceutical Co., Inc. (TSE:4530) Not Lagging Market On Growth Or Pricing
Sep 16Hisamitsu Pharmaceutical's (TSE:4530) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 20Hisamitsu Pharmaceutical (TSE:4530) Has Announced That It Will Be Increasing Its Dividend To ¥45.00
Jul 26Hisamitsu Pharmaceutical (TSE:4530) Is Paying Out A Larger Dividend Than Last Year
Jul 11Hisamitsu Pharmaceutical's (TSE:4530) Dividend Will Be Increased To ¥45.00
Jun 27Hisamitsu Pharmaceutical (TSE:4530) Is Increasing Its Dividend To ¥45.00
Jun 13Why We're Not Concerned About Hisamitsu Pharmaceutical Co., Inc.'s (TSE:4530) Share Price
Apr 09Here's Why We Think Hisamitsu Pharmaceutical (TSE:4530) Is Well Worth Watching
Mar 18CEO
Kazue Nakatomi (52 yo)
9.5yrs
테뉴어
Mr. Kazuhide Nakatomi, also known as Kazue, serves as Chief Executive Officer since May 2019, President since May 2015 & Director since May 2007 at Hisamitsu Pharmaceutical Co. Inc. and served as its Chief...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| President | 9.5yrs | 데이터 없음 | 0.33% ¥ 1.1b | |
| Executive VP | less than a year | 데이터 없음 | 데이터 없음 | |
| Exe Officer of Legal Affairs | 10.5yrs | 데이터 없음 | 0.0068% ¥ 22.4m | |
| Executive MD of Human Resources | less than a year | 데이터 없음 | 0.018% ¥ 58.2m | |
| Senior Managing Executive Officer | less than a year | 데이터 없음 | 데이터 없음 | |
| MD, Executive Officer | no data | 데이터 없음 | 0.0095% ¥ 31.3m | |
| Executive Officer of Mgmt. of Internal Audit Division & Domestic Subsidiary Division and Director | no data | 데이터 없음 | 0.0082% ¥ 26.9m | |
| Senior Executive Officer & GM of Pharmaceutical Business Division | no data | 데이터 없음 | 데이터 없음 | |
| Senior Executive Officer and GM of the Pharmaceuticals & Cosmetics Division | no data | 데이터 없음 | 데이터 없음 | |
| Executive Officer | 3.5yrs | 데이터 없음 | 0.0041% ¥ 13.4m | |
| Senior Executive Officer & GM of MN Business Promotion Office | 1.8yrs | 데이터 없음 | 데이터 없음 | |
| Executive Officer and GM of the Regional Mass Sales Dept of Pharmaceuticals & Cosmetics Division | less than a year | 데이터 없음 | 데이터 없음 |
1.3yrs
평균 재임 기간
58.5yo
평균 연령
경험이 풍부한 관리: 4530's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| President | 17.5yrs | 데이터 없음 | 0.33% ¥ 1.1b | |
| Exe Officer of Legal Affairs | 10.5yrs | 데이터 없음 | 0.0068% ¥ 22.4m | |
| Executive MD of Human Resources | 25.5yrs | 데이터 없음 | 0.018% ¥ 58.2m | |
| MD, Executive Officer | 11.5yrs | 데이터 없음 | 0.0095% ¥ 31.3m | |
| Executive Officer of Mgmt. of Internal Audit Division & Domestic Subsidiary Division and Director | 10.5yrs | 데이터 없음 | 0.0082% ¥ 26.9m | |
| Executive Officer | 3.5yrs | 데이터 없음 | 0.0041% ¥ 13.4m | |
| Standing Corporate Auditor | 18.5yrs | 데이터 없음 | 0.0027% ¥ 9.0m | |
| Part-time Outside Independent Director | 4.5yrs | 데이터 없음 | 0.0014% ¥ 4.5m | |
| Part-time Outside Independent Director | 4.5yrs | 데이터 없음 | 데이터 없음 | |
| Part Time Outside Corporate Auditor | 1.5yrs | 데이터 없음 | 데이터 없음 | |
| Part Time Outside Independent Director | 1.5yrs | 데이터 없음 | 데이터 없음 |
10.5yrs
평균 재임 기간
57yo
평균 연령
경험이 풍부한 이사회: 4530's board of directors are seasoned and experienced ( 10.5 years average tenure).